Compare Wockhardt with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ERIS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ERIS LIFESCIENCES WOCKHARDT/
ERIS LIFESCIENCES
 
P/E (TTM) x -99.5 25.1 - View Chart
P/BV x 1.3 6.1 21.3% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 WOCKHARDT   ERIS LIFESCIENCES
EQUITY SHARE DATA
    WOCKHARDT
Mar-21
ERIS LIFESCIENCES
Mar-21
WOCKHARDT/
ERIS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs570644 88.5%   
Low Rs174367 47.4%   
Sales per share (Unadj.) Rs249.389.3 279.4%  
Earnings per share (Unadj.) Rs62.226.2 237.7%  
Cash flow per share (Unadj.) Rs84.429.3 287.7%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Avg Dividend yield %01.1 0.0%  
Book value per share (Unadj.) Rs302.3115.8 261.1%  
Shares outstanding (eoy) m110.78135.78 81.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.55.7 26.3%   
Avg P/E ratio x6.019.3 30.9%  
P/CF ratio (eoy) x4.417.2 25.6%  
Price / Book Value ratio x1.24.4 28.2%  
Dividend payout %021.0 0.0%   
Avg Mkt Cap Rs m41,18868,637 60.0%   
No. of employees `000NANA-   
Total wages/salary Rs m7,6302,293 332.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m27,62012,119 227.9%  
Other income Rs m1,53487 1,761.9%   
Total revenues Rs m29,15512,206 238.9%   
Gross profit Rs m12,5754,307 291.9%  
Depreciation Rs m2,460430 572.3%   
Interest Rs m2,49120 12,611.6%   
Profit before tax Rs m9,1593,945 232.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,273394 577.3%   
Profit after tax Rs m6,8863,551 193.9%  
Gross profit margin %45.535.5 128.1%  
Effective tax rate %24.810.0 248.7%   
Net profit margin %24.929.3 85.1%  
BALANCE SHEET DATA
Current assets Rs m24,2445,356 452.7%   
Current liabilities Rs m31,1822,354 1,324.4%   
Net working cap to sales %-25.124.8 -101.4%  
Current ratio x0.82.3 34.2%  
Inventory Days Days30109 27.7%  
Debtors Days Days1242 28.7%  
Net fixed assets Rs m49,50811,671 424.2%   
Share capital Rs m554136 407.9%   
"Free" reserves Rs m32,93915,589 211.3%   
Net worth Rs m33,49215,724 213.0%   
Long term debt Rs m5,0290-   
Total assets Rs m73,75217,027 433.2%  
Interest coverage x4.7200.7 2.3%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.40.7 52.6%   
Return on assets %12.721.0 60.6%  
Return on equity %20.622.6 91.0%  
Return on capital %30.225.2 119.9%  
Exports to sales %00-   
Imports to sales %1.81.7 108.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m498201 248.0%   
Fx inflow Rs m1,0090-   
Fx outflow Rs m498201 248.0%   
Net fx Rs m511-201 -254.1%   
CASH FLOW
From Operations Rs m-2,8733,754 -76.5%  
From Investments Rs m14,701-3,234 -454.6%  
From Financial Activity Rs m-11,708-824 1,421.0%  
Net Cashflow Rs m129-304 -42.5%  

Share Holding

Indian Promoters % 67.1 52.7 127.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.0 23.7 12.8%  
FIIs % 2.9 13.3 22.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 32.9 47.3 69.4%  
Shareholders   165,270 54,223 304.8%  
Pledged promoter(s) holding % 47.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

5 Reasons Why Sensex Crashed 1,546 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red. The sell-off continued for the fifth straight session today with benchmark indices losing nearly 3% each.

Related Views on News

WOCKHARDT 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of WOCKHARDT for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WOCKHARDT. Also includes updates on the valuation of WOCKHARDT.

ERIS LIFESCIENCES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of ERIS LIFESCIENCES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ERIS LIFESCIENCES. Also includes updates on the valuation of ERIS LIFESCIENCES.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jan 24, 2022 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - ALKEM LABORATORIES COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS